Using AI to create a vaccine revolution

Clinical stage company Evaxion Biotech is using artificial intelligence (AI) to simulate the immune system and create predictive models to identify novel targets for vaccines against bacterial and viral diseases and immunotherapies for cancer.

Publication: Biopharma Dealmakers

By: Evaxion & Nature Research Custom Media